Benzoyl indoles with metabolic stability as reversal agents for ABCG2-mediated multidrug resistance

scientific article published on 24 June 2019

Benzoyl indoles with metabolic stability as reversal agents for ABCG2-mediated multidrug resistance is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.EJMECH.2019.06.066
P932PMC publication ID6718313
P698PubMed publication ID31302589

P2093author name stringBo Wang
Zhe-Sheng Chen
Pranav Gupta
Yi-Jun Wang
Cai-Ping Tan
Hong Zhai
Yun-Kai Zhang
Zi-Ning Lei
Jing-Quan Wang
Chao-Yun Cai
Bao-Li Chen
Zhao-Yi Du
P4510describes a project that usesImageJQ1659584
P921main subjectmultiple drug resistanceQ643839
P1104number of pages14
P304page(s)849-862
P577publication date2019-06-24
P1433published inEuropean Journal of Medicinal ChemistryQ3008624
P1476titleBenzoyl indoles with metabolic stability as reversal agents for ABCG2-mediated multidrug resistance
P478volume179

Reverse relations

cites work (P2860)
Q90347564Reversal Effect of ALK Inhibitor NVP-TAE684 on ABCG2-Overexpressing Cancer Cells
Q92663055Sitravatinib Sensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs
Q89834270Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer Cells

Search more.